01-01-1970 12:00 AM | Source: Accord Fintech
Supriya Lifescience files DRHP with SEBI for Rs 1,200 crore IPO
Supriya Lifescience has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise Rs 1,200 crore through an initial public offering (IPO).
Proceeds from the fresh issue will be used for funding capital expenditure requirements, repay debt and general corporate purpose. ICICI Securities and Axis Capital have been appointed as merchant bankers to advise the company on the IPO.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.
Latest News
Sensex falls 732 points on profit booking
Evening Roundup : A Daily Report on Bullion Energy &...
Indian jeweller Titan misses Q4 profit view as gold ...
BJP candidate Agnimitra Paul offers prayers at Ram M...
I think it is a perfect team: Rajeev Shukla on India...
FIIs stood as net sellers in equities as per May 03 ...
India likely to be Apple`s 3rd largest market in nex...
Richa Chadha clicked in Mumbai`s Bandra
Post-market comment by Mr Shrey Jain, Founder and CE...
Jashn-e-Jugalbandi: Srinagar?s musical evening promo...